Trusted News Discovery Since 2008
{{/content}}
Cancer Patients Who Are On Medicaid Far Less Likely To Benefit From Clinical Trials
Video Credit: Wochit News
Published on April 30, 2020 - Duration: 00:40s
Cancer Patients Who Are On Medicaid Far Less Likely To Benefit From Clinical Trials
Cancer patients who are uninsured or are on Medicaid benefit less from experimental treatments.
According to UPI, this is true even if they get into clinical trials.
New research reveals Medicaid beneficiaries and the uninsured are only 23% more likely to achieve added survival from an experimental treatment.
People with private health insurance, however, are 66% more likely to derive added survival from interventions still under investigation.
You are here
Related videos from verified sources
Exclusive: Hospital Launches Clinical Trial After New York Doctor Touts Coronavirus Medication Cocktail 03:23
Video credit: CBS 2 New York - Published on April 30, 2020
Clinical Trial Hopes To Find Treatment For COVID-19 Patients 02:21
Video credit: WJZ Baltimore - Published on April 30, 2020
Shares Up On Coronavirus Drug Hopes 00:35
Video credit: Wochit - Published on April 29, 2020